BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 35405368)

  • 1. Haploidentical Stem Cell Transplantation After TCR-αβ
    Giardino S; Bagnasco F; Falco M; Miano M; Pierri F; Risso M; Terranova P; Di Martino D; Massaccesi E; Ricci M; Chianucci B; Dell'Orso G; Sabatini F; Podestà M; Lanino E; Faraci M
    Transplant Cell Ther; 2022 Jul; 28(7):394.e1-394.e9. PubMed ID: 35405368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell receptor αβ
    Shah RM; Elfeky R; Nademi Z; Qasim W; Amrolia P; Chiesa R; Rao K; Lucchini G; Silva JMF; Worth A; Barge D; Ryan D; Conn J; Cant AJ; Skinner R; Abd Hamid IJ; Flood T; Abinun M; Hambleton S; Gennery AR; Veys P; Slatter M
    J Allergy Clin Immunol; 2018 Apr; 141(4):1417-1426.e1. PubMed ID: 28780238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-transplantation of mesenchymal stromal cell and haploidentical hematopoietic stem cell with TCR αβ depletion in children with primary immunodeficiency syndromes.
    Atay D; Akcay A; Akinci B; Yenigurbuz FD; Ovali E; Ozturk G
    Pediatr Transplant; 2021 Dec; 25(8):e14120. PubMed ID: 34409718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Modulation Properties of Zoledronic Acid on TcRγδ T-Lymphocytes After TcRαβ/CD19-Depleted Haploidentical Stem Cell Transplantation: An analysis on 46 Pediatric Patients Affected by Acute Leukemia.
    Merli P; Algeri M; Galaverna F; Milano GM; Bertaina V; Biagini S; Girolami E; Palumbo G; Sinibaldi M; Becilli M; Leone G; Boccieri E; Grapulin L; Gaspari S; Airoldi I; Strocchio L; Pagliara D; Locatelli F
    Front Immunol; 2020; 11():699. PubMed ID: 32477328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD3
    Ramanathan S; Lum SH; Nademi Z; Carruthers K; Watson H; Flood T; Owens S; Williams E; Hambleton S; Gennery AR; Slatter M
    Transplant Cell Ther; 2023 Aug; 29(8):513.e1-513.e9. PubMed ID: 37279857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two cytoreductive regimens for αβ-T-cell-depleted haploidentical HSCT in pediatric malignancies: Improved engraftment and outcome with TBI-based regimen.
    Jacoby E; Varda-Bloom N; Goldstein G; Hutt D; Churi C; Vernitsky H; Toren A; Bielorai B
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28988422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of TCR α
    Brettig T; Smart J; Choo S; Mechinaud F; Mitchell R; Raj TS; Cole T
    J Clin Immunol; 2019 Jul; 39(5):505-511. PubMed ID: 31172381
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotherapy-Free Regimen Improves Non-Relapse Mortality and Immune Recovery Among the Recipients of αβ TCell-Depleted Haploidentical Grafts: Retrospective Study in Childhood Leukemia.
    Shelikhova L; Glushkova S; Nikolaev R; Dunaikina M; Zhekhovtsova Z; Blagov S; Khismatullina R; Balashov D; Kurnikova E; Pershin D; Muzalevskii Y; Kazachenok A; Osipova E; Trakhtman P; Maschan A; Maschan M
    Transplant Cell Ther; 2021 Apr; 27(4):330.e1-330.e9. PubMed ID: 33836878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TCR α
    Mitchell R; Cole T; Shaw PJ; Mechinaud F; O'Brien T; Fraser C
    Pediatr Transplant; 2019 Sep; 23(6):e13517. PubMed ID: 31271477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune Reconstitution Following TCRαβ/CD19-Depleted Hematopoietic Cell Transplantation for Hematologic Malignancy in Pediatric Patients.
    Arnold DE; MacMath D; Seif AE; Heimall JR; Wang Y; Monos D; Grupp SA; Bunin NJ
    Transplant Cell Ther; 2021 Feb; 27(2):169.e1-169.e9. PubMed ID: 33830028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Center Experience of Unrelated and Haploidentical Stem Cell Transplantation with TCRαβ and CD19 Depletion in Children with Primary Immunodeficiency Syndromes.
    Balashov D; Shcherbina A; Maschan M; Trakhtman P; Skvortsova Y; Shelikhova L; Laberko A; Livshits A; Novichkova G; Maschan A
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):1955-62. PubMed ID: 26187864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.
    Foell J; Kleinschmidt K; Jakob M; Troeger A; Corbacioglu S
    Hematol Oncol Stem Cell Ther; 2020 Jun; 13(2):98-105. PubMed ID: 32202248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of children with acute leukemia given HLA-haploidentical HSCT after αβ T-cell and B-cell depletion.
    Locatelli F; Merli P; Pagliara D; Li Pira G; Falco M; Pende D; Rondelli R; Lucarelli B; Brescia LP; Masetti R; Milano GM; Bertaina V; Algeri M; Pinto RM; Strocchio L; Meazza R; Grapulin L; Handgretinger R; Moretta A; Bertaina A; Moretta L
    Blood; 2017 Aug; 130(5):677-685. PubMed ID: 28588018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ
    Gaziev J; Isgrò A; Sodani P; Paciaroni K; De Angelis G; Marziali M; Ribersani M; Alfieri C; Lanti A; Galluccio T; Adorno G; Andreani M
    Blood Adv; 2018 Feb; 2(3):263-270. PubMed ID: 29431621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Conditioning Regimen with Plerixafor Is Safe and Improves the Outcome of TCRαβ
    Balashov D; Laberko A; Shcherbina A; Trakhtman P; Abramov D; Gutovskaya E; Kozlovskaya S; Shelikhova L; Novichkova G; Maschan M; Rumiantsev A; Maschan A
    Biol Blood Marrow Transplant; 2018 Jul; 24(7):1432-1440. PubMed ID: 29550630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. αβ
    Dadi G; Jacoby E; Adam E; Hutt D; Varda-Bloom N; Bielorai B; Toren A
    Pediatr Transplant; 2023 Aug; 27(5):e14531. PubMed ID: 37127942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-Transplantation Immunosuppression After TCRΑβ/CD19 Graft Depletion Does Not Improve HSCT Outcomes in Primary Immunodeficiency.
    Laberko A; Idarmacheva A; Glushkova S; Pershin D; Shelikhova L; Maschan M; Maschan A; Balashov D
    Transplant Cell Ther; 2022 Mar; 28(3):172.e1-172.e4. PubMed ID: 34875404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-haploidentical stem cell transplantation after removal of αβ+ T and B cells in children with nonmalignant disorders.
    Bertaina A; Merli P; Rutella S; Pagliara D; Bernardo ME; Masetti R; Pende D; Falco M; Handgretinger R; Moretta F; Lucarelli B; Brescia LP; Li Pira G; Testi M; Cancrini C; Kabbara N; Carsetti R; Finocchi A; Moretta A; Moretta L; Locatelli F
    Blood; 2014 Jul; 124(5):822-6. PubMed ID: 24869942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience.
    Dell'Orso G; Bagnasco F; Giardino S; Pierri F; Ferrando G; Di Martino D; Micalizzi C; Guardo D; Volpi S; Sabatini F; Miano M; Gattorno M; Dufour C; Faraci M
    Front Immunol; 2023; 14():1103080. PubMed ID: 36825011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TCR-alpha/beta and CD19 depletion and treosulfan-based conditioning regimen in unrelated and haploidentical transplantation in children with acute myeloid leukemia.
    Maschan M; Shelikhova L; Ilushina M; Kurnikova E; Boyakova E; Balashov D; Persiantseva M; Skvortsova Y; Laberko A; Muzalevskii Y; Kazachenok A; Glushkova S; Bobrynina V; Kalinina V; Olshanskaya Y; Baidildina D; Novichkova G; Maschan A
    Bone Marrow Transplant; 2016 May; 51(5):668-74. PubMed ID: 26808573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.